11-78112745-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_024079.5(ALG8):​c.803G>A​(p.Arg268Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0189 in 1,613,666 control chromosomes in the GnomAD database, including 330 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 25 hom., cov: 32)
Exomes 𝑓: 0.019 ( 305 hom. )

Consequence

ALG8
NM_024079.5 missense

Scores

10
5
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 7.33

Publications

13 publications found
Variant links:
Genes affected
ALG8 (HGNC:23161): (ALG8 alpha-1,3-glucosyltransferase) This gene encodes a member of the ALG6/ALG8 glucosyltransferase family. The encoded protein catalyzes the addition of the second glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation of proteins. Mutations in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ih). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ALG8 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • ALG8-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, G2P, Ambry Genetics
  • polycystic liver disease 3 with or without kidney cysts
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_noAF, Cadd, Dann, Eigen, MutationAssessor, REVEL, REVEL [when AlphaMissense, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.017484665).
BP6
Variant 11-78112745-C-T is Benign according to our data. Variant chr11-78112745-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0142 (2153/152146) while in subpopulation NFE AF = 0.0215 (1459/68000). AF 95% confidence interval is 0.0205. There are 25 homozygotes in GnomAd4. There are 972 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024079.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG8
NM_024079.5
MANE Select
c.803G>Ap.Arg268Gln
missense
Exon 8 of 13NP_076984.2A0A024R5K5
ALG8
NM_001425224.1
c.896G>Ap.Arg299Gln
missense
Exon 9 of 14NP_001412153.1
ALG8
NM_001425225.1
c.803G>Ap.Arg268Gln
missense
Exon 8 of 14NP_001412154.1H0YDD3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG8
ENST00000299626.10
TSL:1 MANE Select
c.803G>Ap.Arg268Gln
missense
Exon 8 of 13ENSP00000299626.5Q9BVK2-1
ALG8
ENST00000679559.1
c.803G>Ap.Arg268Gln
missense
Exon 8 of 14ENSP00000505433.1A0A7P0T919
ALG8
ENST00000532440.6
TSL:3
c.803G>Ap.Arg268Gln
missense
Exon 8 of 14ENSP00000433429.2H0YDD3

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2153
AN:
152028
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00488
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0100
Gnomad ASJ
AF:
0.0352
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00270
Gnomad FIN
AF:
0.0176
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.00863
GnomAD2 exomes
AF:
0.0140
AC:
3514
AN:
250846
AF XY:
0.0139
show subpopulations
Gnomad AFR exome
AF:
0.00364
Gnomad AMR exome
AF:
0.00634
Gnomad ASJ exome
AF:
0.0344
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0146
Gnomad NFE exome
AF:
0.0214
Gnomad OTH exome
AF:
0.0149
GnomAD4 exome
AF:
0.0194
AC:
28408
AN:
1461520
Hom.:
305
Cov.:
31
AF XY:
0.0189
AC XY:
13767
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.00323
AC:
108
AN:
33472
American (AMR)
AF:
0.00696
AC:
311
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0359
AC:
939
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.00237
AC:
204
AN:
86216
European-Finnish (FIN)
AF:
0.0157
AC:
837
AN:
53372
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0225
AC:
24973
AN:
1111792
Other (OTH)
AF:
0.0170
AC:
1029
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1478
2956
4435
5913
7391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
938
1876
2814
3752
4690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2153
AN:
152146
Hom.:
25
Cov.:
32
AF XY:
0.0131
AC XY:
972
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.00486
AC:
202
AN:
41532
American (AMR)
AF:
0.0100
AC:
153
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0352
AC:
122
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4810
European-Finnish (FIN)
AF:
0.0176
AC:
186
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0215
AC:
1459
AN:
68000
Other (OTH)
AF:
0.00854
AC:
18
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
114
228
341
455
569
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0194
Hom.:
125
Bravo
AF:
0.0131
TwinsUK
AF:
0.0218
AC:
81
ALSPAC
AF:
0.0226
AC:
87
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.0220
AC:
189
ExAC
AF:
0.0137
AC:
1661
Asia WGS
AF:
0.00202
AC:
8
AN:
3478
EpiCase
AF:
0.0195
EpiControl
AF:
0.0186

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (3)
-
-
2
ALG8 congenital disorder of glycosylation (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Uncertain
0.10
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.86
D
Eigen
Pathogenic
0.94
Eigen_PC
Pathogenic
0.89
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
D
MetaRNN
Benign
0.017
T
MetaSVM
Uncertain
0.70
D
MutationAssessor
Pathogenic
3.4
M
PhyloP100
7.3
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-3.8
D
REVEL
Pathogenic
0.86
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.56
MPC
0.68
ClinPred
0.068
T
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.74
gMVP
0.82
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61995925; hg19: chr11-77823791; API